Navigation Links
Questcor Pharmaceuticals to Present at CLSA's 4th Annual AsiaUSA Forum on November 7, 2011
Date:11/2/2011

ANAHEIM, Calif., Nov. 2, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the 4th Annual CLSA AsiaUSA Forum to be held November 7-9, 2011 in San Francisco.  Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Monday, November 7, 2011 at 2:00 p.m. PT.

A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.  The replay will be available for 90 days after the event.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product, Acthar, helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the use of Acthar to treat systemic lupus erythematosus, or SLE, for which Acthar is approved as both a maintenance therapy and to treat exacerbations.  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.  In October 2011, Forbes magazine ranked Questcor number one in its annual rankings of America's Best Small Companies.  For more information about Questcor, please visit www.questcor.com.


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week
2. Questcor Reports Third Quarter Financial Results
3. Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011
4. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
5. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
6. Questcor Provides Updated New Paid Prescription Trends
7. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
8. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
9. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
10. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
11. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... -- Global Paclitaxel Market 2016 Industry Research ... and the Paclitaxel analysis in this study is supported ... its players. This is the latest Paclitaxel ... current state of the industry while providing a basic ... industry chain structure. The Paclitaxel market analysis is provided ...
(Date:5/23/2016)... , May 23, 2016 The World Health ... PrePex device to include adolescents aged 13 years, and ... can be offered for adult and adolescent males in the ... . PrePex was the first male circumcision device to ... MedTech,s CEO, Eddy Horowitz said: " The ...
(Date:5/23/2016)... May 23, 2016   Purdue Pharma L.P. ... an agreement with Egalet Corporation and Acura Pharmaceuticals, ... part of the agreement the companies will exchange ... all three companies to develop and sell several ... "This agreement reflects the commitment of Purdue Pharma ...
Breaking Medicine Technology:
(Date:5/23/2016)... ... May 23, 2016 , ... On Sunday, May 15, Rockynol ... 64-room assisted living center. After 18 months of construction, the new state-of-the-art structure ... building provides the latest in assisted living amenities and services, offering six different ...
(Date:5/23/2016)... Los Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... bariatric surgeons have noted that, less than 1% of United Kingdom residents who could ... the UK’s National Health Service (NHS) increases the number of bariatric procedures it offers ...
(Date:5/23/2016)... ... May 23, 2016 , ... African-American ... to Georgia State University researchers. , In a recent study published ... and seventh grades shared their experiences with strained relationships, recurring violence, internalized ...
(Date:5/23/2016)... ... May 23, 2016 , ... ComplianceOnline, the leading governance, risk ... medical device summit on September 15 and 16, 2016 in San Diego, CA. ... FDA office bearers will be one of the largest gatherings of medical device companies, ...
(Date:5/23/2016)... PALMYRA, Wis. (PRWEB) , ... May 23, 2016 ... ... held April 29 on its Chesterfield, Missouri, campus, Standard Process Inc. ... Kate Cline, Stephanie Siewert and Chloe Tillman. Each student is in her fifth ...
Breaking Medicine News(10 mins):